API
< Back to all clusters
[BUSINESS] · Brazil · 2 sources

started · updated

Brazil Federal Revenue identifies R$ 1.8 billion in irregular pharmaceutical tax credits

The Brazilian Federal Revenue Service has identified approximately R$ 1.8 billion in irregular reimbursement requests and compensations related to PIS/Pasep and Cofins presumed tax credits for pharmaceutical products. This finding is part of the second phase of Operation Pharmacies, which has reached approximately 1,600 taxpayers.

Of the identified amount, roughly R$ 1.2 billion has already been used in tax compensations, while approximately R$ 439 million in compensations were found to be undeclared. The investigation found that many requests came from companies with economic activities, such as wholesale fruit and vegetable trade, electrical maintenance, and food wholesale, that do not meet the legal requirements for these specific pharmaceutical tax benefits.

This stage of the operation is intended to be advisory, encouraging self-regularization. Affected taxpayers have received communications and have until January 20, 2027, to correct any irregularities.

Entities

Receita Federal